Phylogica patent allowed

By Ruth Beran
Thursday, 29 September, 2005

Perth-based Phylogica (ASX:PYC) has received formal notice of allowance from the European Patent and Trademark Office for its pending patent application entitled: "Isolating biological modulators from biodiverse gene fragment libraries".

The application was filed in 2000 and protects Phylogica's core peptide library technology. Phylogica's proprietary libraries contain millions of phylomers - stable fragments of naturally occurring proteins.

"Not only are the methods for creating these libraries covered but this foundation patent application also describes methods for increasing the diversity of the libraries further," said Phylogica's scientific director Dr Paul Watt in a statement.

Phylogica has eight patent families and cases from the patent family of this recently allowed application have already been granted in Australia and allowed in the US.

Related News

Oxytocin analogue treats chronic abdominal pain

Researchers have developed a new class of oral painkillers to suppress chronic abdominal pain,...

'Low-risk' antibiotic linked to rise of dangerous superbug

A new study has challenged the long-held belief that rifaximin — commonly prescribed to...

Robotic hand helps cultivate baby corals for reef restoration

The soft robotic hand could revolutionise the delicate, labour-intensive process of cultivating...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd